1. Home
  2. FNWD vs ELTX Comparison

FNWD vs ELTX Comparison

Compare FNWD & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWD
  • ELTX
  • Stock Information
  • Founded
  • FNWD 1994
  • ELTX 2011
  • Country
  • FNWD United States
  • ELTX United States
  • Employees
  • FNWD N/A
  • ELTX N/A
  • Industry
  • FNWD Savings Institutions
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNWD Finance
  • ELTX Health Care
  • Exchange
  • FNWD Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • FNWD 121.8M
  • ELTX 121.7M
  • IPO Year
  • FNWD N/A
  • ELTX N/A
  • Fundamental
  • Price
  • FNWD $27.70
  • ELTX $9.89
  • Analyst Decision
  • FNWD Buy
  • ELTX Strong Buy
  • Analyst Count
  • FNWD 1
  • ELTX 2
  • Target Price
  • FNWD $34.00
  • ELTX $11.00
  • AVG Volume (30 Days)
  • FNWD 44.4K
  • ELTX 37.2K
  • Earning Date
  • FNWD 08-05-2025
  • ELTX 08-12-2025
  • Dividend Yield
  • FNWD 1.73%
  • ELTX N/A
  • EPS Growth
  • FNWD N/A
  • ELTX N/A
  • EPS
  • FNWD 0.78
  • ELTX N/A
  • Revenue
  • FNWD $61,430,000.00
  • ELTX N/A
  • Revenue This Year
  • FNWD N/A
  • ELTX N/A
  • Revenue Next Year
  • FNWD $6.97
  • ELTX N/A
  • P/E Ratio
  • FNWD $35.71
  • ELTX N/A
  • Revenue Growth
  • FNWD N/A
  • ELTX N/A
  • 52 Week Low
  • FNWD $26.12
  • ELTX $3.70
  • 52 Week High
  • FNWD $33.50
  • ELTX $10.39
  • Technical
  • Relative Strength Index (RSI)
  • FNWD 49.11
  • ELTX 75.55
  • Support Level
  • FNWD $26.70
  • ELTX $9.14
  • Resistance Level
  • FNWD $28.50
  • ELTX $10.39
  • Average True Range (ATR)
  • FNWD 0.67
  • ELTX 0.57
  • MACD
  • FNWD 0.07
  • ELTX 0.08
  • Stochastic Oscillator
  • FNWD 60.78
  • ELTX 79.34

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: